Given that the systemic levels of insulin, glucagon, and free fatty acids were comparable in the pulsatile, constant and T2D-mimicking infusions, it was presumed that hepatocyte insulin receptor mediated pathways contribute mainly to the observed enhancement in glucose control18. The gene discussed is INS; the disease is type 2 diabetes mellitus.